EVAXION BIOTECH A S EVAX
ADS · ADR · CUSIP 29970R105
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.95. Options: 5 managers hold calls ($1.2m notional), 2 hold puts ($73.0k).
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 11 |
| Q2 2021 | 8 |
| Q3 2021 | 8 |
| Q4 2021 | 13 |
| Q1 2022 | 13 |
| Q2 2022 | 10 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2021 | 3 | 7 |
| Q3 2021 | 4 | 4 |
| Q4 2021 | 12 | 2 |
| Q1 2022 | 6 | 8 |
| Q2 2022 | 3 | 9 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2021 | $0 | $0 | — |
| Q4 2021 | $735.0k | $61.0k | 0.08 |
| Q1 2022 | $1.1m | $38.0k | 0.04 |
| Q2 2022 | $1.2m | $73.0k | 0.06 |
Biggest buyers
| CITADEL ADVISORS LLC | Added | +70.8k |
| RENAISSANCE TECHNOLOGIES LLC | New | +11.6k |
| GROUP ONE TRADING LLC | New | +100 |
Biggest sellers
| LUMINUS MANAGEMENT LLC | Sold out | -424.5k |
| Telemetry Investments, L.L.C. | Reduced | -46.7k |
| Kepos Capital LP | Sold out | -30.0k |
| TWO SIGMA INVESTMENTS, LP | Sold out | -20.6k |
| ETF MANAGERS GROUP, LLC | Sold out | -7.0k |
| MORGAN STANLEY | Reduced | -4.1k |
| UBS Group AG | Reduced | -853 |
| CITIGROUP INC | Reduced | -254 |
| SIMPLEX TRADING, LLC | Sold out | -55 |
Biggest calls
| CITADEL ADVISORS LLC | Added | $650.0k333.1k shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Added | $376.0k192.8k shares |
| GROUP ONE TRADING LLC | New | $118.0k60.7k shares |
| SIMPLEX TRADING, LLC | New | $59.0k31.1k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CITADEL ADVISORS LLC | Added | $73.0k37.3k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Telemetry Investments, L.L.C. 0.36% of their portfolio | 122.0k $238.0k | Reduced -46.7k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 83.6k $163.0k | Added +70.8k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 11.6k $22.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 4.3k $8.0k | Reduced -4.1k |
| CITIGROUP INC 0.00% of their portfolio | 2.9k $6.0k | Reduced -254 |
| UBS Group AG 0.00% of their portfolio | 1.1k $2.0k | Reduced -853 |
| Steward Partners Investment Advisory, LLC 0.00% of their portfolio | 1.0k $2.0k | Unchanged |
| CAPTRUST FINANCIAL ADVISORS 0.00% of their portfolio | 339 $1.0k | Unchanged |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 100 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |